INVEGA TRINZA

Janssen Pharmaceuticals, Inc🇺🇸 United States

FDA Page

Effective Date: Mar 23, 2022
Approval ID: c39e65d7-fa44-4e4c-8b12-a654d3ed0eae
Products: 4 registered
Version: 19

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006

Quick Stats

Total Products4

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.